Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: Pharmaceutical Physicians, Clinical Pharmacologists, and Medical Toxicologists
+ Sample video: contact me for sample video
+ Information:
The CASSS US Manufacturing Virtual Summit 2026 is a specialized virtual program dedicated to exploring the strategic, infrastructural, and regulatory dimensions of biopharmaceutical manufacturing in the United States. The summit brings together industry leaders, facility engineers, and regulatory experts to address critical challenges in manufacturing onshoring, facility design, supply chain resilience, workforce development, and navigating complex post-approval changes.
Learning Objectives
-
Evaluate insights and innovative approaches for US manufacturing onshoring in comparison to European landscapes.
-
Analyze strategies for building state-of-the-art manufacturing facilities and executing operational playbook changes at an unprecedented pace.
-
Design capability architectures to engineer future workforce capacity and enhance supply chain resilience for the biomanufacturing wave.
-
Master regulatory compliance aspects, inspection success protocols, and informational frameworks regarding the FDA PreCheck Program.
-
Navigate the complexities of post-approval changes and deliver compliant, efficient solutions within commercial and clinical manufacturing operations.
Target Audience
- This program is designed for professionals in the biopharmaceutical industry, including manufacturing engineers, regulatory affairs specialists, quality assurance and control experts, and supply chain leaders.
- Best for Pharmaceutical Physicians, Clinical Pharmacologists, and Medical Toxicologists.
Topics
-
Accelerating US Manufacturing Onshoring: EU Landscape Insights and Innovative Approaches
-
Building It Is the Easy Part, Changing the Playbook Is Harder
-
Capability Architecture: Engineering the Future Workforce for Supply Chain Resilience
-
CASSS Welcome: Virtual Summit US Manufacturing 2026 Introduction
-
Delivering State-of-the-Art Manufacturing Facilities at an Unprecedented Pace
-
Ensuring Inspection Success
-
Post-Approval Changes: Navigating Complexity, Delivering Solutions
-
Regulatory Aspects Introduction: Informational Slides on FDA PreCheck Program
-
Session I: Infrastructure and Building (including Panel Discussion)
-
Session II: Regulatory Aspects (including Welcome, Summary, and Concluding Remarks)
-
Virtual Summit Manufacturing 2026 Scientific Program and Summary Infographic
-
Workforce Capacity & Training: Building the Pipeline for the US Biomanufacturing Wave
Reviews
There are no reviews yet.